Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Alliance News) - Stock prices in London are seen opening slightly higher on Monday, tracking gains in Chinese equity markets despite a reported slowdown in economic growth there.In early UK news,
15 Jul 19 07:40(Alliance News) - AstraZeneca PLC on Friday said it has secured Orphan Drug Designation for small cell lung cancer treatment Imfinzi from the US Food & Drug Administration.The FDA Drug
12 Jul 19 08:56(Alliance News) - AstraZeneca PLC on Monday said it has received positive opinions in the EU for drugs Forixga and Fasenra.The European Medicines Agency's Committee for Medicinal for EU
1 Jul 19 08:56(Sharecast News) - Rightmove: UBS downgrades to sell with a target price of 505p.
27 Jun 19 11:16(Alliance News) - AstraZeneca PLC on Thursday said interim analysis of its Caspian trial of Imfinzi showed the drug improved overall survival in extensive-stage small cell lung analysis of the had
27 Jun 19 10:55(Sharecast News) - Biopharmaceutical company AstraZeneca revealed some positive overall survival results from its Phase III CASPIAN trial with Imfinzi, a human monoclonal antibody.
27 Jun 19 08:28(Alliance News) - AstraZeneca PLC on Wednesday announced drug approvals in Japan, including Lynparza for advanced ovarian cancer and Breztri Aerosphere for chronic obstructive pulmonary Aerosphere
19 Jun 19 08:30(Alliance News) - Stocks in London on Wednesday are set to build on the previous session's gains as traders await the latest decision from the US Federal Reserve in the wake of dovish comments
19 Jun 19 07:47(Sharecast News) - AstraZeneca announced three new drug approvals in Japan on Wednesday, with the first for 'Breztri Aerosphere' (budesonide/glycopyrronium/ formoterol fumarate) - formerly PT010 - as a triple-combination therapy to relieve symptoms of chronic obstructive pulmonary disease (COPD).
19 Jun 19 07:29(Alliance News) - An unremarkable start to the day for London stocks picked up mid-morning as dovish comments from European Central Bank President Mario Draghi boosted equities across Europe. - is
18 Jun 19 16:59(Alliance News) - Seemingly not wanting to be left out in a week that features policy meetings of the US Federal Reserve and the Bank of England, the head of the European Central Bank was the of a
18 Jun 19 11:51(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Ashtead,
18 Jun 19 10:23(Alliance News) - Stock prices in London opened flat on Tuesday, with Ashtead rising after strong annual results, helping the FTSE 100 to outperform other European indices.The UK
18 Jun 19 08:49(Sharecast News) - AstraZeneca and its partner MSD announced on Tuesday that the European Commission (EC) has approved 'Lynparza' (olaparib) as a first-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer.
18 Jun 19 07:28(Sharecast News) - AstraZeneca announced detailed results from the interim analysis of the phase 3 'ASCEND' trial on Monday, showing Calquence (acalabrutinib) significantly prolonged the time patients lived without disease progression in relapsed or refractory chronic lymphocytic leukaemia (CLL).
17 Jun 19 07:24
Last checked at